Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: A case report [5]

Journal of Clinical Psychopharmacology

Volumn 20, Issue 5, 2000, Pages 584-585

  Sekine, Y ^a   Iyo, M ^a   Tanaka, K ^a   Matsuyama, K ^a   Matsunaga, T ^a   Mori, N ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; METHYLPHENIDATE; MIANSERIN;

AGED; BRAIN INFARCTION; CASE REPORT; DELIRIUM; DEPRESSION; DOSE RESPONSE; DRUG USE; FEMALE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CEREBRAL INFARCTION; DEPRESSIVE DISORDER; DOPAMINE UPTAKE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHYLPHENIDATE; MIANSERIN;

EID: 0033835761     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200010000-00019     Document Type: Letter

References (7)

1. 'Vascular depression' hypothesis
2. MRI-defined vascular depression
3. Response of patients with major depression and silent cerebral infarction to antidepressant drug therapy, with emphasis on central nervous system adverse reactions
4. Drugs and other physical treatments
5. Mirtazapine: Clinical advantages in the treatment of depression
6. Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series
7. Efficacy and side effects of methylphenidate for poststroke depression